In conclusion, GLP-1 receptor agonists did not increase or decrease the risk of thyroid cancer, hyperthyroidism, hypothyroidism, thyroiditis, thyroid mass and goiter
(For small-molecule drugs like semaglutide, at least seven years must have passed from its FDA approval date to be eligible for selection, and for drugs with multiple FDA approvals, CMS will use the earliest approval date to make this determination.) If that happens, a negotiated Medicare price would be available beginning in 2027
Metformin does not improve the reproductive or metabolic profile in women with polycystic ovary syndrome (PCOS)
Sculpt Pro contains ingredients at doses that actually do something, not just doses that look good on a label
Achrekar SK, Modi DN, Meherji PK, Patel ZM, Mahale SD (2010) Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea